Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation
| Autor: | Ali Fuat Çiçek, Deniz Dogan, Ergun Tozkoparan, Orhan Yücel, Nesrin Öcal |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Thorax 010407 polymers medicine.drug_class medicine.medical_treatment government.form_of_government lcsh:Medicine Case Report 01 natural sciences Acute eosinophilic pneumonia sputum eosinophilia synthetic cannabinoid 03 medical and health sciences medicine Acute eosinophilic pneumonia Inhalation business.industry lcsh:R General Medicine SPUTUM EOSINOPHILIA sputum eosinophilia Eosinophil 0104 chemical sciences 030104 developmental biology medicine.anatomical_structure Respiratory failure Anesthesia government Corticosteroid Cannabinoid synthetic cannabinoid business |
| Zdroj: | Balkan Medical Journal, Vol 33, Iss 6, Pp 688-690 (2016) Volume: 33, Issue: 6 688-690 Balkan Medical Journal |
| ISSN: | 2146-3131 2146-3123 |
| Popis: | Background: In recent days, synthetic cannabinoid derivatives have become life threatening for young people. Here, we want to share a case of acute eosinophilic pneumonia triggered by inhalation of synthetic cannabinoid, new side effects of which are being detected day by day. Case Report: A 21-year-old male, who had no history of pulmonary diseases, was admitted to the clinic with shortness of breath. His oxygen saturation was measured as 85-86% in room air. Common irregular ground-glass opacities were observed in thorax radiology. His peripheral blood eosinophil count was 1100 cell/mm³ with a leukocyte differential of 12%. Sputum eosinophilia was also observed. The patient was diagnosed with acute eosinophilic pneumonia in terms of current clinical, radiological and laboratory findings. Rapid remission was achieved with corticosteroid therapy. Conclusion: This is the first reported case of acute eosinophilic pneumonia induced by synthetic cannabinoid inhalation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|